Cabot Profit Booster 193

The one trade from the September expiration cycle that was not closed last week was CFX, which leaves us with the stock and no option position. While it is possible that CFX will rebound in the days/weeks to come, because of the market weakness, am...
Read More

Cabot Undervalued Stocks Advisor Weekly Update

After a stunningly strong market so far this year, with the S&P 500 producing a 20% total return through Monday, the slow grind-down of most stocks since early September has seemed interminable. The 1,100 largest stocks in our 3,000-stock database have declined only in...
Read More

Cabot Early Opportunities Special Bulletin

Today we’re stepping away from our remaining three-quarter position in long-term holding 10X Genomics (TXG), which we added in December 2019. The stock has been moving sideways since January, and this week management spoke at conferences and suggested it is seeing lower-than-expected lab during...
Read More

The Right Time for a Cash Out Refinance

The Right Time for a Cash Out Refinance

With residential property values skyrocketing and persistent low interest rates, now just might be the perfect time for a cash out refinance. If you’ve been following the news, or even caught sight of a headline out of the corner of your eye, you have seen...
Read More

Cabot Explorer 744

With more than 10,000 baby boomers reaching 65 each day in America, you can bet that medical services aimed at this giant group are growth markets.
Read More